Samsung Biologics, the biotech arm of Samsung Group, has agreed to return to the negotiation table this week, a corporate official said on Sunday.<\/p>\n
The two sides will renegotiate on Monday under the mediation of the Jungbu regional employment and labor office, after the first round of talks fell through on Thursday. <\/p>\n
The strike is the first ever for the union, with the walkout entering its third day on Sunday, reports Yonhap news agency. <\/p>\n
“Our decision to respond to the labor ministry’s arbitration request during the walkout was part of our sincere efforts to sort the issue out through dialogue,” a company source said. <\/p>\n
The representative urged the labor union to stop its “irrational” demands and collective action and return to the negotiation table. <\/p>\n
During the first arbitration meeting held last week, the labor union reportedly demanded the company change all of its bargaining committee members as a prerequisite for talks. <\/p>\n
Unionized workers of Samsung Biologics have been staging a strike since Friday. They have demanded a 14 percent increase in both base and performance-related pay, a one-off cash incentive of 30 million won (US$20,389.9) per worker, and bonuses equivalent to 20 percent of annual operating profit. <\/p>\n
The company has proposed a combined 6.2 percent increase in base and performance pay. <\/p>\n
Around 2,800 of 4,000 unionized members have participated in the collective action, according to the company’s labour union. <\/p>\n
The company claims the walkout could cause at least 640 billion won worth of damage, which is equivalent to around half of the company’s sales for the first quarter. <\/p>\n
The union said it plans to continue the strike until Tuesday. <\/p>\n
Unionized workers of Samsung Biologics called for the company to establish “fair and transparent” personnel management standards. <\/p>\n
“What the labour union demands is that the management should exercise personnel and management authority in a transparent manner so that the employees can work while trusting the company,” the labor union said in a release. <\/p>\n
The labour union is said to have proposed a collective bargaining agreement that includes clauses requiring prior consent by the union in regard to new hiring, personnel evaluations and decisions on mergers and acquisitions.<\/p>\n","protected":false},"excerpt":{"rendered":"Samsung Biologics, the biotech arm of Samsung Group, has agreed to return to the negotiation table this week,…\n","protected":false},"author":2,"featured_media":1165,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[1238,1239,1236,1234,1233,1242,1241,1237,1240,127,505,1235],"class_list":["post-1164","post","type-post","status-publish","format-standard","has-post-thumbnail","category-samsung-biologics","tag-640-billion-won-damage","tag-bargaining-committee","tag-base-pay-increase","tag-collective-bargaining-agreement","tag-jungbu-regional-employment-office","tag-mediation-arbitration","tag-operating-profit-bonus","tag-performance-related-pay","tag-personnel-management","tag-samsung","tag-samsung-biologics","tag-yonhap-news-agency"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/posts\/1164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/comments?post=1164"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/posts\/1164\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/media\/1165"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/media?parent=1164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/categories?post=1164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/korea\/wp-json\/wp\/v2\/tags?post=1164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}